BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 8252188)

  • 1. Lymphangioleiomyomatosis: unsuccessful treatment with luteinizing-hormone-releasing hormone analogues.
    de la Fuente J; Páramo C; Román F; Pérez R; Masa C; de Letona JM
    Eur J Med; 1993; 2(6):377-8. PubMed ID: 8252188
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of pulmonary lymphangioleiomyomatosis using a GnRH agonist].
    Desurmont S; Bauters C; Copin MC; Dewailly D; Tonnel AB; Wallaert B
    Rev Mal Respir; 1996 Jul; 13(3):300-4. PubMed ID: 8765924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Lymphangioleiomyomatosis a rare disease in a young women].
    Lommi J; Sirén J; Laine T; Purhonen M; Jeskaner L; Härkönen M
    Duodecim; 1997; 113(2):149-52. PubMed ID: 11370045
    [No Abstract]   [Full Text] [Related]  

  • 4. [Two cases of pulmonary lymphangioleiomyomatosis].
    Tao Y; Yoshii C; Nikaido Y; Tsuda T; Nagata N; Kido M; Kodate M; Shirakusa T
    Nihon Kyobu Shikkan Gakkai Zasshi; 1993 Sep; 31(9):1157-62. PubMed ID: 8255028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High dose progesterone therapy in lymphangioleiomyomatosis: a case report and review of literature.
    Ho AY; Lam B; Ooi CC; Tan KC; Tsang KW
    Chin Med J (Engl); 1998 Aug; 111(8):759-61. PubMed ID: 11245037
    [No Abstract]   [Full Text] [Related]  

  • 6. Sirolimus treatment for recurrent lymphangioleiomyomatosis after lung transplantation.
    Chen F; Omasa M; Kondo N; Fujinaga T; Shoji T; Sakai H; Bando T
    Ann Thorac Surg; 2009 Jan; 87(1):e6-7. PubMed ID: 19101258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Doxycycline treatment for lymphangioleiomyomatosis with urinary monitoring for MMPs.
    Moses MA; Harper J; Folkman J
    N Engl J Med; 2006 Jun; 354(24):2621-2. PubMed ID: 16775248
    [No Abstract]   [Full Text] [Related]  

  • 8. Lymphangioleiomyomatosis.
    Fernández-Fernández FJ; Buño-Ramilo B; Sesma P
    Eur J Intern Med; 2009 Jan; 20(1):e24. PubMed ID: 19237077
    [No Abstract]   [Full Text] [Related]  

  • 9. Response to treatment with progesterone in a patient with pulmonary lymphangioleiomyomatosis.
    Rajjoub S; Blatt MW; Ritterspach J
    W V Med J; 1995; 91(7):322-3. PubMed ID: 8533401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Luteinizing hormone-releasing hormone analogues and hormone ablation for prostate cancer: state of the art.
    Schally AV
    BJU Int; 2007 Jul; 100 Suppl 2():2-4. PubMed ID: 17594347
    [No Abstract]   [Full Text] [Related]  

  • 11. The role of luteinizing hormone-releasing hormone therapy in locally advanced prostate cancer and biochemical failure: considerations for optimal use.
    Teillac P; Bono AV; Irani J; Wirth MP; Zlotta AR
    Clin Ther; 2005 Mar; 27(3):273-85. PubMed ID: 15878381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A case of pulmonary lymphangioleiomyomatosis.
    Ramphal PS; Shah D; Mitchell DI; Wynter-Daley J
    West Indian Med J; 2003 Sep; 52(3):250-2. PubMed ID: 14649111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Spontaneous pneumothorax in young women: possible lymphangioleiomyomatosis].
    Louis H; Los H; Lagendijk JH; de Graaff CS; Postmus PE
    Ned Tijdschr Geneeskd; 1997 Oct; 141(40):1924-8. PubMed ID: 9550739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A clinician's guide to the use of gonadotropin-releasing hormone analogues in women.
    Moghissi KS
    Medscape Womens Health; 2000 Jan; 5(1):5. PubMed ID: 10792849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined therapy with luteinizing hormone releasing hormone agonist (LHRHa) and growth hormone (GH) in central precocious puberty.
    Volta C; Regazzi C; Ndaka J; Vitale R; Bernasconi S
    Acta Biomed; 2005 Sep; 76(2):73-8. PubMed ID: 16350551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Therapeutic use of luteinizing hormone-releasing hormone].
    Mićić J; Nesović M; Popović V; Micić D
    Srp Arh Celok Lek; 1988 Apr; 116(4):355-69. PubMed ID: 3055344
    [No Abstract]   [Full Text] [Related]  

  • 17. Advanced indications for gonadotropin-releasing hormone (GnRH) analogues in gynecological oncology (review).
    Sugiyama M; Imai A; Takahashi S; Hirano S; Furui T; Tamaya T
    Int J Oncol; 2003 Aug; 23(2):445-52. PubMed ID: 12851694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum luteinizing hormone, follicle-stimulating hormone and oestradiol pattern in women undergoing pituitary suppression with different gonadotrophin-releasing hormone analogue protocols for assisted reproduction.
    Manna C; Rahman A; Sbracia M; Pappalardo S; Mohamed EI; Linder R; Nardo LG
    Gynecol Endocrinol; 2005 Apr; 20(4):188-94. PubMed ID: 16019360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Gonadotropin-releasing hormone analogs].
    Krysiak R; Okopień B; Herman ZS
    Pol Merkur Lekarski; 2005 May; 18(107):585-9. PubMed ID: 16161962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pulmonary densities following a hysterectomy, caused by benign metastatic leiomyoma].
    Scheer ML; Slebos DJ; Bogchelman DH; Timens W
    Ned Tijdschr Geneeskd; 2008 Sep; 152(37):2027-31. PubMed ID: 18825892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.